Noronha, V., Menon, N. S., Patil, V. M., Shah, M. J., Ostwal, V., Ramaswamy, A., Bhargava, P. G., Shah, S., Nawale, K. P., Shetake, A., Badwe, R. A., Prabhash, K. (2025). Phase III randomized study comparing ultra-low dose immunotherapy to standard cytotoxic chemotherapy for solid tumors in second line and beyond setting (DELII: Development of Low dose Immunotherapy in India).. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.2509